Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 1, 2023 · 10-Q · 31 days after period end · 0001069530-23-000017
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$24.27M | -$17.53M | -$3.53M | -$1.15M |
| EPS Diluted | -$0.58 | -$0.44 | -$0.09 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 1, 2023 · 31 d after period end
